Contact

All Stories

  1. Outside-in induction of the IFITM3 trafficking system by infections, including SARS-CoV-2, in the pathobiology of Alzheimer’s disease

    Article • Brain Behavior & Immunity - Health, July 2021, Elsevier

    Professor Sygkliti (Sigliti)-Henrietta (Errieta) Pelidou

  2. Double hit viral parasitism, polymicrobial CNS residency and perturbed proteostasis in Alzheimer’s disease: A data driven, in silico analysis of gene expression data

    Article • Molecular Immunology, November 2020, Elsevier

    Professor Sygkliti (Sigliti)-Henrietta (Errieta) Pelidou

  3. Factors related to the adverse events of antiepileptic drugs

    Article • Epilepsy & Behavior, October 2020, Elsevier

    Professor Sygkliti (Sigliti)-Henrietta (Errieta) Pelidou

  4. Spontaneous, isolated, and gaze-evoked ocular flutter: A rare case report

    Article • Clinical Case Reports, April 2020, Wiley

    Professor Sygkliti (Sigliti)-Henrietta (Errieta) Pelidou, Assistant Professor in Neurology Sygkliti-Henrietta Pelidou

  5. Deciphering anti-MOG IgG antibodies: Clinical and radiological spectrum, and comparison of antibody detection assays

    Article • Journal of the Neurological Sciences, March 2020, Elsevier

    Professor Sygkliti (Sigliti)-Henrietta (Errieta) Pelidou

  6. Reduced expression of L-selectin in T-cells correlates with relative lymphocyte increase in patients with RRMS treated with natalizumab - functional implication towards PML risk

    Article • Neurological Research, February 2020, Taylor & Francis

    Professor Sygkliti (Sigliti)-Henrietta (Errieta) Pelidou, Assistant Professor in Neurology Sygkliti-Henrietta Pelidou, PANAGIOTIS IOANNIDIS

  7. Psychological distress symptoms and illness perception in patients with epilepsy in Northwest Greece

    Article • Epilepsy & Behavior, January 2020, Elsevier

    Professor Sygkliti (Sigliti)-Henrietta (Errieta) Pelidou

  8. Reasons for Failed Trials of Disease-Modifying Treatments for Alzheimer Disease and Their Contribution in Recent Research

    Article • Biomedicines, December 2019, MDPI AG

    Professor Sygkliti (Sigliti)-Henrietta (Errieta) Pelidou, Assistant Professor in Neurology Sygkliti-Henrietta Pelidou

  9. Reasons for Failed trials of Disease-modifying Treatments for Alzheimer Disease and their Contribution in Recent Research

    Article • September 2019, MDPI AG

    Professor Sygkliti (Sigliti)-Henrietta (Errieta) Pelidou

  10. Depression and quality of life in patients with epilepsy in Northwest Greece

    Article • Seizure, March 2019, Elsevier

    Professor Sygkliti (Sigliti)-Henrietta (Errieta) Pelidou, Assistant Professor in Neurology Sygkliti-Henrietta Pelidou

  11. pentoxifylline to the reduction in the elastic modulus of human red blood cells

    Article • Biomaterials Science, January 2019, Royal Society of Chemistry

    Professor Stavros J Baloyannis or Balogiannis or Balojannis or Baloyiannis or Mpalogiannis, Professor Sygkliti (Sigliti)-Henrietta (Errieta) Pelidou, Assistant Professor in Neurology Sygkliti-Henrietta Pelidou

  12. Plasma lipid peroxidation biomarkers for early and non-invasive Alzheimer Disease detection

    Article • Free Radical Biology and Medicine, August 2018, Elsevier

    Professor Sygkliti (Sigliti)-Henrietta (Errieta) Pelidou

  13. The effectiveness of hydrokinesiotherapy on postural balance of hemiplegic patients after stroke: a systematic review and meta-analysis

    Article • Clinical Rehabilitation, December 2017, SAGE Publications

    Georgia Iatridou, Professor Sygkliti (Sigliti)-Henrietta (Errieta) Pelidou, Assistant Professor in Neurology Sygkliti-Henrietta Pelidou

  14. The Efficacy of Natalizumab versus Fingolimod for Patients with Relapsing-Remitting Multiple Sclerosis: A Systematic Review, Indirect Evidence from Randomized Placebo-Controlled Trials and Meta-Analysis of Observational Head-to-Head Trials

    Article • PLoS ONE, September 2016, PLOS

    Professor Sygkliti (Sigliti)-Henrietta (Errieta) Pelidou, PANAGIOTIS IOANNIDIS

  15. Disk Herniation or ependymoma recurrence?

    Article • Neuroimmunology and Neuroinflammation, March 2016, OAE Publishing

    Professor Sygkliti (Sigliti)-Henrietta (Errieta) Pelidou, Assistant Professor in Neurology Sygkliti-Henrietta Pelidou

  16. The effect of menarche age, parity and lactation on bone mineral density in premenopausal ambulatory multiple sclerosis patients

    Article • Multiple Sclerosis and Related Disorders, July 2015, Elsevier

    Professor Sygkliti (Sigliti)-Henrietta (Errieta) Pelidou

  17. Alzheimer and glaucoma associations

    Article • Clinical Ophthalmology, October 2014, Taylor & Francis

    Professor Sygkliti (Sigliti)-Henrietta (Errieta) Pelidou, Assistant Professor in Neurology Sygkliti-Henrietta Pelidou

  18. AUTOIMMUNE DISEASES IN MS PATIENTS

    Article • Acta Neurologica Scandinavica, October 2014, Wiley

    Professor Sygkliti (Sigliti)-Henrietta (Errieta) Pelidou, Assistant Professor in Neurology Sygkliti-Henrietta Pelidou

  19. Risk factors for cognitive dysfunction in CKD and hypertensive subjects

    Article • International Urology and Nephrology, May 2013, Springer Science + Business Media

    Professor Sygkliti (Sigliti)-Henrietta (Errieta) Pelidou

  20. Capturing the elasticity and morphology of live fibroblast cell cultures during degradation with atomic force microscopy

    Article • Journal of Microscopy, November 2012, Wiley

    Professor Sygkliti (Sigliti)-Henrietta (Errieta) Pelidou, Assistant Professor in Neurology Sygkliti-Henrietta Pelidou

  21. High-dose intravenous immunoglobulin in the treatment of adult patients with bullous pemphigoid

    Article • European Journal of Dermatology, May 2012, John Libbey Eurotext

    Professor Sygkliti (Sigliti)-Henrietta (Errieta) Pelidou

  22. Body Composition in Ambulatory Patients With Multiple Sclerosis

    Article • Journal of Clinical Densitometry, October 2011, Elsevier

    Professor Sygkliti (Sigliti)-Henrietta (Errieta) Pelidou

  23. HLA associations with multiple sclerosis in Greece

    Article • Journal of the Neurological Sciences, September 2011, Elsevier

    Professor Sygkliti (Sigliti)-Henrietta (Errieta) Pelidou, Assistant Professor in Neurology Sygkliti-Henrietta Pelidou

  24. IC-P-022: Reversible dementia as first symptom of multiple myeloma: A case report

    Article • Alzheimer s & Dementia, July 2011, Wiley

    Professor Sygkliti (Sigliti)-Henrietta (Errieta) Pelidou, Assistant Professor in Neurology Sygkliti-Henrietta Pelidou

  25. Bone mineral density in ambulatory patients with multiple sclerosis

    Article • Neurological Sciences, May 2011, Springer Science + Business Media

    Professor Sygkliti (Sigliti)-Henrietta (Errieta) Pelidou

  26. Vitamin D receptor gene polymorphisms in multiple sclerosis patients in northwest Greece

    Article • Journal of Negative Results in BioMedicine, May 2011, Springer Science + Business Media

    Professor Sygkliti (Sigliti)-Henrietta (Errieta) Pelidou

  27. Perimetric and peri-papillary nerve fibre layer thickness findings in multiple sclerosis

    Article • European Journal of Neurology, November 2010, Wiley

    Professor Sygkliti (Sigliti)-Henrietta (Errieta) Pelidou

  28. MRI Deterioration in Herpes Simplex Encephalitis Despite Clinical Recovery

    Article • The Neurologist, July 2009, Wolters Kluwer Health

    Professor Sygkliti (Sigliti)-Henrietta (Errieta) Pelidou

  29. Agenesis of the corpus callosum associated with narcolepsy–cataplexy

    Article • Sleep Medicine, February 2009, Elsevier

    Professor Sygkliti (Sigliti)-Henrietta (Errieta) Pelidou, Assistant Professor in Neurology Sygkliti-Henrietta Pelidou

  30. Periventricular nodular heterotopia and epilepsy

    Article • Internal Medicine Journal, August 2008, Wiley

    Professor Sygkliti (Sigliti)-Henrietta (Errieta) Pelidou

  31. Thrombosis and Recanalization of Straight Sinus

    Article • Pediatric Emergency Care, August 2008, Wolters Kluwer Health

    Professor Sygkliti (Sigliti)-Henrietta (Errieta) Pelidou, Assistant Professor in Neurology Sygkliti-Henrietta Pelidou

  32. Multiple sclerosis presented as clinically isolated syndrome: the need for early diagnosis and treatment

    Article • Therapeutics and Clinical Risk Management, June 2008, Taylor & Francis

    Assistant Professor in Neurology Sygkliti-Henrietta Pelidou, Professor Sygkliti (Sigliti)-Henrietta (Errieta) Pelidou

  33. Multiple-Organ Cavernous Hemangiomas Involving Brain, Skin, and Lung

    Article • Cornea, January 2008, Wolters Kluwer Health

    Professor Sygkliti (Sigliti)-Henrietta (Errieta) Pelidou

  34. Isolated headache as the sole manifestation of dural sinus thrombosis

    Article • The American Journal of Emergency Medicine, October 2007, Elsevier

    Professor Sygkliti (Sigliti)-Henrietta (Errieta) Pelidou

  35. Lateral medullary ischaemic events in young adults with hypoplastic vertebral artery

    Article • Journal of Neurology Neurosurgery & Psychiatry, September 2007, BMJ

    Professor Sygkliti (Sigliti)-Henrietta (Errieta) Pelidou

  36. Brainstem mass and testicular tuberculosis

    Article • Journal of Neurology, July 2007, Springer Science + Business Media

    Professor Sygkliti (Sigliti)-Henrietta (Errieta) Pelidou

  37. Cognitive Impairment in Patients with Neuropathic Pain

    Article • Journal of Pain and Symptom Management, July 2007, Elsevier

    Professor Sygkliti (Sigliti)-Henrietta (Errieta) Pelidou, Assistant Professor in Neurology Sygkliti-Henrietta Pelidou

  38. Neurological manifestations of connective tissue diseases mimicking multiple sclerosis

    Article • Rheumatology International, June 2007, Springer Science + Business Media

    Professor Sygkliti (Sigliti)-Henrietta (Errieta) Pelidou

  39. Burden of Illness in Painful Diabetic Peripheral Neuropathy

    Article • Journal of Pain, June 2007, Elsevier

    Professor Sygkliti (Sigliti)-Henrietta (Errieta) Pelidou

  40. VERTEBRAL ARTERY HYPOPLASIA: A PREDISPOSING FACTOR FOR POSTERIOR CIRCULATION STROKE?

    Article • Neurology, May 2007, Wolters Kluwer Health

    Professor Sygkliti (Sigliti)-Henrietta (Errieta) Pelidou

  41. Patient Compliance With SSRIs and Gabapentin in Painful Diabetic Neuropathy

    Article • Clinical Journal of Pain, March 2007, Wolters Kluwer Health

    Professor Sygkliti (Sigliti)-Henrietta (Errieta) Pelidou

  42. Multiple sclerosis associated with systemic sclerosis

    Article • Rheumatology International, December 2006, Springer Science + Business Media

    Professor Sygkliti (Sigliti)-Henrietta (Errieta) Pelidou

  43. Increased sensitivity to N-methyl-d-aspartate receptor-induced excitotoxicity in cerebellar granule cells from interleukin-1 receptor type I-deficient mice

    Article • Journal of Neuroimmunology, December 2002, Elsevier

    Professor Sygkliti (Sigliti)-Henrietta (Errieta) Pelidou

  44. Erratum to “PO glycoprotein peptides 56–71 and 180–199 dose-dependently induce acute and chronic experimental autoimmune neuritis in Lewis rats associated with epitope spreading” [J. Neuroimmunol. 114 (2001) 106]

    Article • Journal of Neuroimmunology, September 2001, Elsevier

    Professor Sygkliti (Sigliti)-Henrietta (Errieta) Pelidou

  45. P0 glycoprotein peptides 56–71 and 180–199 dose-dependently induce acute and chronic experimental autoimmune neuritis in Lewis rats associated with epitope spreading

    Article • Journal of Neuroimmunology, March 2001, Elsevier

    Professor Sygkliti (Sigliti)-Henrietta (Errieta) Pelidou, Assistant Professor in Neurology Sygkliti-Henrietta Pelidou

  46. HIGH INFLAMMATION AND MILD DEMYELINATION IN THE PERIPHERAL NERVOUS SYSTEM INDUCED BY AN INTRANEURAL INJECTION OF RR INTERLEUKIN-4

    Article • Cytokine, June 2000, Elsevier

    Professor Sygkliti (Sigliti)-Henrietta (Errieta) Pelidou, Assistant Professor in Neurology Sygkliti-Henrietta Pelidou

  47. Enhancement of Acute Phase and Inhibition of Chronic Phase of Experimental Autoimmune Neuritis in Lewis Rats by Intranasal Administration of Recombinant Mouse Interleukin 17: Potential Immunoregulatory Role

    Article • Experimental Neurology, May 2000, Elsevier

    Professor Sygkliti (Sigliti)-Henrietta (Errieta) Pelidou

  48. Rolipram suppresses experimental autoimmune neuritis and prevents relapses in Lewis rats

    Article • Neuropharmacology, February 2000, Elsevier

    Professor Sygkliti (Sigliti)-Henrietta (Errieta) Pelidou

  49. Intranasal Administration of Recombinant Mouse Interleukin-12 Increases Inflammation and Demyelination in Chronic Experimental Autoimmune Neuritis in Lewis Rats

    Article • Scandinavian Journal of Immunology, January 2000, Wiley

    Professor Sygkliti (Sigliti)-Henrietta (Errieta) Pelidou

  50. Protective Effect of Rolipram in Experimental Autoimmune Neuritis: Protection is Associated with Down-Regulation of IFN-γ and Inflammatory Chemokines as Well as Up-Regulation of IL-4 in Peripheral Nervous System

    Article • Autoimmunity, January 2000, Taylor & Francis

    Professor Sygkliti (Sigliti)-Henrietta (Errieta) Pelidou, Assistant Professor in Neurology Sygkliti-Henrietta Pelidou

  51. Increased IL-1β, IL-8, and IL-17 mRNA Expression in Blood Mononuclear Cells Observed in a Prospective Ischemic Stroke Study

    Article • Stroke, October 1999, Wolters Kluwer Health

    Professor Sygkliti (Sigliti)-Henrietta (Errieta) Pelidou, Assistant Professor in Neurology Sygkliti-Henrietta Pelidou

  52. Dynamics of production of MIP-1α, MCP-1 and MIP-2 and potential role of neutralization of these chemokines in the regulation of immune responses during experimental autoimmune neuritis in Lewis rats

    Article • Journal of Neuroimmunology, August 1999, Elsevier

    Professor Sygkliti (Sigliti)-Henrietta (Errieta) Pelidou

  53. Local effects of recombinant rat interleukin-6 on the peripheral nervous system

    Article • Immunology, August 1999, Wiley

    Professor Sygkliti (Sigliti)-Henrietta (Errieta) Pelidou

  54. Inflammation and Severe Demyelination in the Peripheral Nervous System Induced by the Intraneural Injection of Recombinant Mouse Interleukin-12

    Article • Scandinavian Journal of Immunology, July 1999, Wiley

    Professor Sygkliti (Sigliti)-Henrietta (Errieta) Pelidou

  55. High levels of IL-10 secreting cells are present in blood in cerebrovascular diseases

    Article • European Journal of Neurology, July 1999, Wiley

    Professor Sygkliti (Sigliti)-Henrietta (Errieta) Pelidou

  56. Suppression of chronic experimental autoimmune neuritis by nasally administered recombinant rat interleukin‐6

    Article • Immunology, May 1999, Wiley

    Professor Sygkliti (Sigliti)-Henrietta (Errieta) Pelidou, Assistant Professor in Neurology Sygkliti-Henrietta Pelidou

  57. Nasal Administration of Recombinant Rat IL-4 Ameliorates Ongoing Experimental Autoimmune Neuritis and Inhibits Demyelination

    Article • Journal of Autoimmunity, March 1999, Elsevier

    Professor Sygkliti (Sigliti)-Henrietta (Errieta) Pelidou